Literature DB >> 30218255

Human Genetic Variation and HIV/AIDS in Papua New Guinea: Time to Connect the Dots.

Rajeev K Mehlotra1.   

Abstract

PURPOSE OF REVIEW: Human genetic polymorphisms known to influence HIV acquisition and disease progression occur in Papua New Guinea (PNG). However, no genetic association study has been reported so far. In this article, we review research findings, with a view to stimulate genotype-to-phenotype research. RECENT
FINDINGS: PNG, a country in Oceania, has a high prevalence of HIV and many sexually transmitted infections. While limited data is available from this country regarding the distribution of human genetic polymorphisms known to influence clinical outcomes of HIV/AIDS, genetic association studies are lacking. Our studies, in the past decade, have revealed that polymorphisms in chemokine receptor-ligand (CCR2-CCR5, CXCL12), innate immune (Toll-like receptor, β-defensin), and antiretroviral drug-metabolism enzyme (CYP2B6, UGT2B7) genes are prevalent in PNG. Although our results need to be validated in further studies, it is urgent to pursue large-scale, comprehensive genetic association studies that include these as well as additional genetic polymorphisms.

Entities:  

Keywords:  CCR5; CYP2B6; HIV/AIDS. Human genetic variation; Papua New Guinea

Mesh:

Year:  2018        PMID: 30218255     DOI: 10.1007/s11904-018-0417-9

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  98 in total

1.  Prevalence of UGT1A9 and UGT2B7 nonsynonymous single nucleotide polymorphisms in West African, Papua New Guinean, and North American populations.

Authors:  Rajeev K Mehlotra; Moses J Bockarie; Peter A Zimmerman
Journal:  Eur J Clin Pharmacol       Date:  2006-11-09       Impact factor: 2.953

2.  CYP2B6 983T>C polymorphism is prevalent in West Africa but absent in Papua New Guinea: implications for HIV/AIDS treatment.

Authors:  Rajeev K Mehlotra; Moses J Bockarie; Peter A Zimmerman
Journal:  Br J Clin Pharmacol       Date:  2007-03-28       Impact factor: 4.335

3.  Copy Number Variation within Human β-Defensin Gene Cluster Influences Progression to AIDS in the Multicenter AIDS Cohort Study.

Authors:  Rajeev K Mehlotra; Jean-Eudes Dazard; Bangan John; Peter A Zimmerman; Aaron Weinberg; Richard J Jurevic
Journal:  J AIDS Clin Res       Date:  2012

4.  Evolution of Pacific/Asian populations inferred from HLA class II allele frequency distributions.

Authors:  S J Mack; T L Bugawan; P V Moonsamy; J A Erlich; E A Trachtenberg; Y K Paik; A B Begovich; N Saha; H P Beck; M Stoneking; H A Erlich
Journal:  Tissue Antigens       Date:  2000-05

Review 5.  Pharmacogenomics in Papua New Guineans: unique profiles and implications for enhancing drug efficacy while improving drug safety.

Authors:  Joseph D Tucci; Paul P Pumuye; Nuala A Helsby; Daniel T Barratt; Percy P Pokeya; Francis Hombhanje; Andrew A Somogyi
Journal:  Pharmacogenet Genomics       Date:  2018-06       Impact factor: 2.089

6.  Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure.

Authors:  W A Paxton; S R Martin; D Tse; T R O'Brien; J Skurnick; N L VanDevanter; N Padian; J F Braun; D P Kotler; S M Wolinsky; R A Koup
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

7.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

8.  A genomic history of Aboriginal Australia.

Authors:  Anna-Sapfo Malaspinas; Michael C Westaway; Craig Muller; Vitor C Sousa; Oscar Lao; Isabel Alves; Anders Bergström; Georgios Athanasiadis; Jade Y Cheng; Jacob E Crawford; Tim H Heupink; Enrico Macholdt; Stephan Peischl; Simon Rasmussen; Stephan Schiffels; Sankar Subramanian; Joanne L Wright; Anders Albrechtsen; Chiara Barbieri; Isabelle Dupanloup; Anders Eriksson; Ashot Margaryan; Ida Moltke; Irina Pugach; Thorfinn S Korneliussen; Ivan P Levkivskyi; J Víctor Moreno-Mayar; Shengyu Ni; Fernando Racimo; Martin Sikora; Yali Xue; Farhang A Aghakhanian; Nicolas Brucato; Søren Brunak; Paula F Campos; Warren Clark; Sturla Ellingvåg; Gudjugudju Fourmile; Pascale Gerbault; Darren Injie; George Koki; Matthew Leavesley; Betty Logan; Aubrey Lynch; Elizabeth A Matisoo-Smith; Peter J McAllister; Alexander J Mentzer; Mait Metspalu; Andrea B Migliano; Les Murgha; Maude E Phipps; William Pomat; Doc Reynolds; Francois-Xavier Ricaut; Peter Siba; Mark G Thomas; Thomas Wales; Colleen Ma'run Wall; Stephen J Oppenheimer; Chris Tyler-Smith; Richard Durbin; Joe Dortch; Andrea Manica; Mikkel H Schierup; Robert A Foley; Marta Mirazón Lahr; Claire Bowern; Jeffrey D Wall; Thomas Mailund; Mark Stoneking; Rasmus Nielsen; Manjinder S Sandhu; Laurent Excoffier; David M Lambert; Eske Willerslev
Journal:  Nature       Date:  2016-09-21       Impact factor: 49.962

9.  Association of chemokine receptor gene (CCR2-CCR5) haplotypes with acquisition and control of HIV-1 infection in Zambians.

Authors:  Rakhi Malhotra; Liangyuan Hu; Wei Song; Ilene Brill; Joseph Mulenga; Susan Allen; Eric Hunter; Sadeep Shrestha; Jianming Tang; Richard A Kaslow
Journal:  Retrovirology       Date:  2011-03-23       Impact factor: 4.602

10.  A Toll-like receptor-1 variant and its characteristic cellular phenotype is associated with severe malaria in Papua New Guinean children.

Authors:  L Manning; J Cutts; D I Stanisic; M Laman; A Carmagnac; S Allen; A O'Donnell; H Karunajeewa; A Rosanas-Urgell; P Siba; T M E Davis; P Michon; L Schofield; K Rockett; D Kwiatkowski; I Mueller
Journal:  Genes Immun       Date:  2015-12-03       Impact factor: 2.676

View more
  1 in total

1.  Large variability in plasma efavirenz concentration in Papua New Guinea HIV/AIDS patients associated with high frequency of CYP2B6 516T allele.

Authors:  Natália Bordin Andriguetti; Helena Katherina Van Schalkwyk; Daniel Thomas Barratt; Joseph Tucci; Paul Pumuye; Andrew Alexander Somogyi
Journal:  Clin Transl Sci       Date:  2021-08-20       Impact factor: 4.689

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.